Labiotech.eu

Interview 8 May 2017

Meet the co-developer of the first commercial mAb and gene therapy

Sander van Deventer is now a managing partner at Forbion after playing a critical role in the development of the first commercial monoclonal antibody, Remicade, and the first market-approved gene therapy, Glybera. I was curious to know what he did to achieve such an impressive track record. Sander van Deventer was trained as an internist […]

May 8, 2017 - 5 minutesmins - By Philip Hemme

More News! 6 May 2017

Color Patterns in the Clothes of the Future will be Made by Bacteria

Natsai Audrey Chieza is an artist and researcher exploring the integration of life into the manufacturing of the materials of the future. Natsai Audrey Chieza wants to break with the current paradigm of fashion design and textile production with the help of microbiology. Her research focuses on developing bacterial biopigments for textiles to replace the […]

May 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 5 May 2017

Forget Chemical Synthesis, Yeast can Now Synthesize Complex Antibiotics

A new study presents a novel synthetic biology approach for antibiotic synthesis in yeast that could tackle the huge challenge of antibiotic resistance. Scientists at Imperial College London have hacked their way into introducing complex biosynthesis pathways in the baker’s yeast Saccharomyces cerevisiae. In particular, they focused on the production of non-ribosomal peptides (Nrp), a group of […]

May 5, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 4 May 2017

Video Interview: This Biotech Wants to Take Over the NOTCH Space

Cellestia, based in Basel, is a biotech spin-off from EPFL, developing new compounds targeting the NOTCH pathway for the treatment of cancer. Its CEO, Michael Bauer, talked to Philip at our recent meetup in Basel and explained what sets Cellestia apart from other players in the field. Cellestia was founded in 2014, based on the […]

May 4, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 4 May 2017

Solid First-in-Human Results from Vaccine against Birth Defects

Hookipa has presented positive data from its first Phase I trial testing its vaccine technology against human cytomegalovirus (hCMV) infections. Hookipa, one of the top 10 biotechs we’re closely following this year, is developing a viral vaccine platform that has attracted big investments from both the private and the public sector. The company just announced […]

May 4, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

vivet therapeutics gene therapy fundraising

News and Trends 4 May 2017

French Gene Therapy Biotech Raises a Huge €37.5M in Series A

Vivet Therapeutics has raised a huge €37.5M in Series A to help bring a new gene therapy technology for rare liver diseases to the clinic. Vivet Therapeutics has managed to attract some of the hottest biotech investors in Europe in its Series A. Led by Novartis Venture Fund and Columbus Venture Partners, and also counting […]

May 4, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 May 2017

Parent Bacteria Resist Antibiotics Better than their Offspring

According to a new study, a phenomenon known as biased inheritance protects older bacteria from the wrath of antibiotics in low concentrations. Older bacteria in a mixed population of dividing E. coli cells inherit a larger number of drug-expelling membrane proteins and pump out antibiotics better than their younger counterparts in the presence of low […]

May 4, 2017 - 3 minutesmins - By External Contributor

Interview 4 May 2017

This Belgian Startup is building the Next Generation of Diagnostic Tests

DNAlytics changes the diagnosing game. The company builds in vitro diagnosis tests that save many years for patients! I met with Thibault, the founder, to know more about the company. Based in Louvain-La-Neuve, Belgium, DNAlytics develops revolutionary disease diagnostic processes that complement conventional methods. Their main product is RheumaKit, a test that analyzes biological and clinical […]

May 4, 2017 - 5 minutesmins - By External Contributor

News and Trends 3 May 2017

Immuno-oncology Pioneer Enters the Clinic with its RNA-based Therapy

Rigontec has announced the start if its first-in-human Phase I/II study with its pioneering RNA-based candidate, RGT100, in solid tumors and lymphoma. Rigontec, based in Munich, is exploring RNA’s applications in immuno-oncology. Since the company was founded in 2014, it has raked in an impressive €30M in series A funding. Now, only 3 years later, the biotech is […]

May 3, 2017 - 2 minutesmins - By Melanie De Almeida

More News! 3 May 2017

German Pharma Investigates Genetics of Pain to Personalize Treatment

At the height of the opioid epidemic, Grünenthal has partnered up with 23andMe to explore the genetic factors associated with pain. Though opioid abuse has not been as rampant in Europe as it has in the United States, German pharma Grünenthal, which focuses on pain, inflammation and gout, has staked out a position in the fight. Today, […]

May 3, 2017 - 3 minutesmins - By Evelyn Warner

News and Trends 3 May 2017

E-GUIDE: This is how you bring a molecule to the clinic

May 3, 2017 - 0 minutesmins - By External Contributor

News and Trends 3 May 2017

New Immuno-oncology Biotech Gets a €20M Series A Funding Boost

Imcheck Therapeutics from Marseille has just completed a €20M Series A funding round, backed by big investors like the Boehringer Ingelheim Venture Fund (BIVF). The French biotech Imcheck Therapeutics was founded in 2015 as a spin-off from the Paoli-Calmettes Cancer Institute (IPC) in Marseille and is developing next-generation immunomodulatory antibodies for the treatment of cancer and autoimmune diseases. […]

May 3, 2017 - 2 minutesmins - By Melanie De Almeida

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Meet the co-developer of the first commercial mAb and gene therapy

Color Patterns in the Clothes of the Future will be Made by Bacteria

Forget Chemical Synthesis, Yeast can Now Synthesize Complex Antibiotics

Video Interview: This Biotech Wants to Take Over the NOTCH Space

Solid First-in-Human Results from Vaccine against Birth Defects

French Gene Therapy Biotech Raises a Huge €37.5M in Series A

Parent Bacteria Resist Antibiotics Better than their Offspring

This Belgian Startup is building the Next Generation of Diagnostic Tests

Immuno-oncology Pioneer Enters the Clinic with its RNA-based Therapy

German Pharma Investigates Genetics of Pain to Personalize Treatment

E-GUIDE: This is how you bring a molecule to the clinic

New Immuno-oncology Biotech Gets a €20M Series A Funding Boost

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!